Latest News & Analysis

stocks
3 undervalued ASX companies with sound balance sheets
I love investing in companies that boast strong financial positions. These three cheap ASX shares could fit the bill and screen cheaply according to our analysts.
3 undervalued ASX companies with sound balance sheets
3 undervalued ASX companies with sound balance sheets
stocks
Overpriced ASX company too successful in wrong channel

Overpriced ASX company too successful in wrong channel

Booming online sales cannibalising more profitable in-store sales.
personal-finance
It is going to be a long four years: Mark’s top articles in March

It is going to be a long four years: Mark’s top articles in March

Morningstar’s Director of Personal Finance was focused on volatility and tariffs in March - just like everyone else.
stocks
More promising signs for ASX listed software player

More promising signs for ASX listed software player

This moated small-cap looks undervalued versus our forecasts. Let alone management’s more ambitious growth targets.
markets
Is the US headed for a recession? What analysts are saying about Q1’s GDP decline

Is the US headed for a recession? What analysts are saying about Q1’s GDP decline

The slowdown comes as US firms stock up on inventory ahead of Trump’s tariffs.
personal-finance
An enlightened dividend path

An enlightened dividend path

While many chase high yields, true investment power lies in companies that steadily grow dividends. This strategy, rooted in patience and discipline, quietly compounds wealth and anchors investors through market turbulence.
personal-finance
Are you smarter than a year 12 student?

Are you smarter than a year 12 student?

I recently presented a personal finance assignment given to year 12 students and here is one reader’s attempt at answering the question.
personal-finance
Young & Invested: The beginner ETF portfolio

Young & Invested: The beginner ETF portfolio

Diving into ETFs can often be overwhelming.
personal-finance
Sim’s monthly insights for April

Sim’s monthly insights for April

A break from business as usual.
stocks
Overvalued ASX pharma play hits FDA speedbump

Overvalued ASX pharma play hits FDA speedbump

We think a delay rather than an outright rejection for this company’s product is the likelier outcome, but the shares still look expensive.
markets
9 charts on Trump’s first 100 days in US markets

9 charts on Trump’s first 100 days in US markets

Wall Street expected bull markets, but got intense volatility and uncertainty instead.
retirement
What returns do you need for a comfortable retirement?

What returns do you need for a comfortable retirement?

The math behind your retirement outcomes. 
stocks
Going into earnings, is Meta stock a buy, a sell, or fairly valued?

Going into earnings, is Meta stock a buy, a sell, or fairly valued?

Watching AI monetization, Reels profitability, and Reality Labs spending, here’s what we think of Meta stock.
stocks
Alphabet earnings: Solid results as AI monetization continues to improve

Alphabet earnings: Solid results as AI monetization continues to improve

We continue to view the stock as materially undervalued.
stocks
The most hated company on the ASX 200 right now

The most hated company on the ASX 200 right now

Down close to 75% in the last year is this share a bargain?
personal-finance
Future Focus: My investment portfolio used to be gold bangles

Future Focus: My investment portfolio used to be gold bangles

Ways that women have taken back financial control.
of 596
Viewing 1 to 16 of 9532